Fussell Stephen R 4
4 · ABBOTT LABORATORIES · Filed Feb 26, 2019
Insider Transaction Report
Form 4
Fussell Stephen R
Senior Vice President
Transactions
- Award
Common shares without par value
2019-02-22+26,350→ 187,402 total - Award
Option (right to buy)
2019-02-22+138,121→ 138,121 totalExercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common shares (138,121 underlying)
Holdings
- 1,683(indirect: By Trust)
Common shares without par value
- 53(indirect: By Spouse)
Common shares without par value
Footnotes (4)
- [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 22, 2019.
- [F3]The reporting person disclaims beneficial ownership of all securities held by his spouse.
- [F4]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 46,040 on February 22, 2020, 46,040 on February 22, 2021, and 46,041 on February 22, 2022.